Stock listing
SLXN Stock Price, News, Filings & Events — Silexion Therapeutics Corp
Selected listing: SLXN · BOATS · USD · US
This page tracks Silexion Therapeutics Corp's SLXN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLXN:BOATS. SLXN:BOATS is the stock-level entry point for investors researching Silexion Therapeutics Corp, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Silexion Therapeutics Corp, trading under the ticker SLXN, is a public company based in America with a market capitalization of approximately $2.41 million. The company focuses on developing innovative therapeutic solutions. Investors can find relevant information about Silexion's operations and market performance on its dedicated public company page.

- Ticker
- SLXN:BOATS
- Asset type
- Stock
- Market cap
- $2.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Silexion Therapeutics Corp SLXN:BOATS stock context
This page tracks Silexion Therapeutics Corp's SLXN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLXN:BOATS. SLXN:BOATS is the stock-level entry point for investors researching Silexion Therapeutics Corp, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Silexion Therapeutics Corp, trading under the ticker SLXN, is a public company based in America with a market capitalization of approximately $2.41 million. The company focuses on developing innovative therapeutic solutions. Investors can find relevant information about Silexion's operations and market performance on its dedicated public company page.
Latest news from Silexion Therapeutics Corp
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
September 9, 2026
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 14, 2026
Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
August 11, 2026
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourask...
July 29, 2026
Silexion Activates First Site in Phase 2/3 Trial Targeting KRAS-Driven Pancreatic Cancer (NASDAQ: SLXN)
July 29, 2026
Research Silexion Therapeutics Corp
Silexion Therapeutics Corp investor report
Review AI stock analysis and investor report context for SLXN:BOATS.
Silexion Therapeutics Corp company profile
View the public company page for Silexion Therapeutics Corp on 6ix.
Silexion Therapeutics Corp news
Read company news and market updates connected to Silexion Therapeutics Corp.
Silexion Therapeutics Corp investor events
Find investor webinars, events, and replay context for Silexion Therapeutics Corp.